2021
DOI: 10.1016/j.bbr.2021.113339
|View full text |Cite
|
Sign up to set email alerts
|

Effects of intrastriatal injection of the dopamine receptor agonist SKF38393 and quinpirole on locomotor behavior in hemiparkinsonism rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 70 publications
0
2
0
Order By: Relevance
“…Numerous studies have shown that dopaminergic deficiency in the CPu contributes to cognitive decline and motor deficits in PD (McCoy et al, 2019). For instance, intra-CPu infusion of a D1R agonist or D2R agonist efficiently improved motor dysfunction in 6-OHDA-induced PD rats (M. Guo et al, 2021).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Numerous studies have shown that dopaminergic deficiency in the CPu contributes to cognitive decline and motor deficits in PD (McCoy et al, 2019). For instance, intra-CPu infusion of a D1R agonist or D2R agonist efficiently improved motor dysfunction in 6-OHDA-induced PD rats (M. Guo et al, 2021).…”
Section: Introductionmentioning
confidence: 99%
“…Numerous studies have shown that dopaminergic deficiency in the CPu contributes to cognitive decline and motor deficits in PD (McCoy et al, 2019 ). For instance, intra‐CPu infusion of a D1R agonist or D2R agonist efficiently improved motor dysfunction in 6‐OHDA‐induced PD rats (M. Guo et al, 2021 ). Additionally, the enhancement of dopaminergic signals in the CPu was consistent with improvements in both motor function and cognition of PD participants (Darvas et al, 2014 ; McCoy et al, 2019 ).…”
Section: Introductionmentioning
confidence: 99%